Search Results for keywords:"performance goals"

Found 2 results

Search Results: keywords:"performance goals"

💰 Only
Oldest Newest
  • 2025-01831 — Postal Service Performance Report and Performance Plan
    Type:Notice
    Citation:90 FR 8309
    Reading Time:about 5 minutes

    The Postal Regulatory Commission has released a notice regarding the Postal Service's FY 2024 Performance Report and the FY 2025 Performance Plan. The notice informs the public about these documents, invites them to submit comments by March 14, 2025, and reply comments by March 28, 2025. The report evaluates the Postal Service's performance goals for fiscal year 2024, which include providing high-quality service and a safe workplace, and outlines plans for fiscal year 2025. The Commission is looking for public feedback on whether the goals were met and on any recommendations for future improvements.

    Simple Explanation

    The Postal Service shared a report about how well they did last year and their plans for next year, and they want to hear what people think about it. People can tell them their thoughts by March 14, 2025, and more thoughts by March 28, 2025.

  • 2025-02153 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biosimilars User Fee Program
    Type:Notice
    Citation:90 FR 8804
    Reading Time:about 6 minutes

    The Food and Drug Administration (FDA) is asking for public comments on its data collection efforts related to the Biosimilars User Fee Program, which supports the development of biosimilar drugs. The program, part of the Biologics Price Competition and Innovation Act, helps guide the approval process for biosimilars by allowing companies to pay user fees to the FDA. These fees are collected to ensure the safe and effective development of these drugs. Companies interested in participating should submit comments by March 5, 2025, and can find more information on the FDA's website.

    Simple Explanation

    The FDA wants to know what people think about collecting money from companies to help make new medicines that are similar to ones they already sell. This money is used to make sure the new medicines are safe and effective.